Individualizing Insulin Therapy for Type 2 Diabetes Mellitus
Activity Overview
Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentation using link located at the bottom of this page.
Release Date: October 17, 2016
Expiration Date: March 1, 2018
Activity Type: Knowledge-based
CE Credits: 1 hour (0.1 CEU), no partial credit
Activity Fee: Free of charge
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists with an interest in diabetes management and new drug therapies who practice in hospitals, health systems, ambulatory clinics, specialty pharmacies, and community pharmacies.
Activity Content
This educational activity provides an overview of the clinical impact of type 2 diabetes mellitus. The use of individualized insulin therapy is explained with an emphasis on new insulin options. Optimization of this therapy is discussed based on glycemic profiles, adverse effects, and safety.
Learning Objectives
After the conclusion of this knowledge-based educational activity, participants should be able to- Describe the clinical impact of type 2 diabetes mellitus.
- Explain the use of individualized insulin therapy in current treatment guidelines for type 2 diabetes mellitus.
- Compare the pharmacokinetic and pharmacodynamic parameters of insulin formulations and delivery methods.
- Devise strategies for overcoming adverse effects and safety issues in insulin-treated patients.
Faculty
Andrew S. Bzowyckyj, Pharm.D., BCPS, CDE
Clinical Assistant Professor
University of Missouri-Kansas City School of Pharmacy
Truman Medical Centers – Hospital Hill
Kansas City, Missouri
Andrew S. Bzowyckyj, Pharm.D., BCPS, CDE, is Clinical Assistant Professor at the University of Missouri-Kansas City (UMKC) School of Pharmacy in Kansas City, Missouri. He also maintains an active clinical practice site in the outpatient internal medicine and endocrinology clinics at Truman Medical Centers – Hospital Hill (TMC-HH), where he provides comprehensive medication management for patients approximately three days per week. A large portion of his teaching responsibilities involves precepting student pharmacists for ambulatory introductory and advanced pharmacy practice experiences and postgraduate year 1 (PGY1) residents for an elective rotation.
Dr. Bzowyckyj earned his Doctor of Pharmacy degree from the University of Connecticut School of Pharmacy in Storrs and completed an ASHP-accredited PGY1 residency at the University of Minnesota College of Pharmacy in the 24-month Pharmaceutical Care Leadership Residency program. He is board certified in pharmacotherapy through the Board of Pharmaceutical Specialties and is a certified diabetes educator through the National Certification Board for Diabetes Educators.
Since joining the team at TMC-HH, Dr. Bzowyckyj has provided Diabetes Self-Management Education (DSME) to outpatients enrolled in the American Diabetes Association-accredited program (individual and group education) in addition to conducting individual medication management visits with complex patients with diabetes and numerous other comorbidities. At UMKC, he teaches within the didactic pharmacy curriculum on a variety of topics, including thyroid disorders, dyslipidemia, diabetes, health policy, professional advocacy, and pharmacy practice leadership and management. He is currently an advisor for the UMKC chapter of the American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP).
Dr. Bzowyckyj is a member of ASHP, APhA, American Association of Colleges of Pharmacy, American College of Clinical Pharmacy, and American Association of Diabetes Educators, in addition to several state and local affiliated organizations. He currently serves as an elected officer or appointed member of several committees related to pharmacy practice and education.
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Associate Director of Experiential Education
Associate Professor
Department of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, is Associate Director of Experiential Education and Associate Professor in the Department of Pharmacy Practice at Midwestern University Chicago College of Pharmacy in Downers Grove, Illinois. Dr. Cornell is also a clinical pharmacy consultant and certified diabetes educator, specializing in community and ambulatory care practice.
Dr. Cornell’s current clinical practice is with Bolingbrook Christian Health Clinic and Will-Grundy Medical Clinic. She trains, educates, and supervises students from the colleges of medicine, pharmacy, and health sciences as they provide diabetes education classes, individual diabetes care, and medication therapy management for patients in underserved community clinics.
Dr. Cornell received her Bachelor of Science degree in pharmacy from the University of Illinois College of Pharmacy and her Doctor of Pharmacy degree from Midwestern University.
Dr. Cornell is a past president of the Illinois Pharmacists Association. She has received numerous awards and recognitions, including the 2014 Bowl of Hygeia, 2011 Outstanding Faculty Advisor Award, 2010 Teacher of the Year Award, and 2005 Midwestern University Golden Apple Teaching Award. She is an active member of the American Diabetes Association and American Association of Diabetes Educators (AADE), previously serving of the board of directors for AADE. Dr. Cornell has given numerous presentations to healthcare professionals and community groups, and she has authored and contributed to many peer-reviewed print and online articles in the field of diabetes education.
Joshua J. Neumiller, Pharm.D., CDE, FASCP
Vice Chair and Associate Professor
Department of Pharmacotherapy
Washington State University College of Pharmacy
Spokane, Washington
Joshua J. Neumiller, Pharm.D., CDE, FASCP, is Vice Chair and Associate Professor in the Department of Pharmacotherapy at Washington State University College of Pharmacy in Spokane, Washington.
Dr. Neumiller earned a Bachelor of Science degree in general science and a Doctor of Pharmacy degree from Washington State University in Spokane, Washington. He is a certified diabetes educator (CDE) and a fellow of the American Society of Consultant Pharmacists (ASCP).
Dr. Neumiller’s research interests involve the management of diabetes and prevention of adverse drug events during transitions in care. He is Editor-in-Chief for Diabetes Spectrum, a journal of the American Diabetes Association (ADA). He also is a contributing author for the ADA books, Medications for the Treatment of Diabetes, Practical Insulin, and American Diabetes Association Guide to Nutrition Therapy for Diabetes.
Dr. Neumiller is a member of ADA, ASCP, American Association of Diabetes Educators, American Pharmacists Association, and Washington State Pharmacy Association. He was recently awarded the 2016 Albert B. Prescott Pharmacy Leadership Award from the Pharmacy Leadership and Education Institute.
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
Andrew S. Bzowyckyj, Pharm.D.,BCPS, CDE, declares that he has no relationships pertinent to this activity.
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, declares that she has served on speaker bureaus and on advanced practitioner advisory boards for Novo Nordisk Inc. and Sanofi and has divested herself of these relationships.
Joshua J. Neumiller, Pharm.D., CDE, FASCP, declares that he has served as a consultant for Eli Lilly and Sanofi and on a speakers bureau for Novo Nordisk Inc. He has also received research grants from AstraZeneca, Johnson & Johnson, and Novo Nordisk Inc.
Curtis L. Triplitt, Pharm.D., CDE, declares that he has served on the speakers bureau for AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., and Novo Nordisk Inc. He has also served as a consultant for AstraZeneca and Sanofi.
· All other planners report no financial relationships relevant to this activity.
Methods & CE Requirements
This is an online activity consisting of audio and slides, an assessment, and a course evaluation. Participants should claim continuing education credit for this home-study educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity assessment (a minimum score of 70% is required), and complete the course evaluation to receive continuing education credit. The handout includes slides and the assessment for your reference.
CPE credit will be processed through ASHP’s eLearning portal. On the last slide of the presentation you must click the “Close Activity and Process CE” button to complete the online process for obtaining credit. Alternatively, you can process your CPE credit directly at the eLearning portal. Per ACPE, CPE credit must be claimed no later than 60 days from the date of completion of a home-study activity. CPE credit will be reported directly to CPE Monitor.
Agenda
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus
Andrew S. Bzowyckyj, Pharm.D., BCPS, CDE, and Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Faculty Discussion and Audience Questions (optional)
Please read the following information about this continuing education (CE) activity before accessing the presentation using the link located at the bottom of this page.
Launch Presentation (60 minutes)*
*Allow additional time to complete the assessment and evaluation.
